This is the first prevalence study of Mycoplasma genitalium and antimicrobial resistance study in Ireland. In urine samples from men who have sex with men (n = 400) attending a sexually transmitted disease clinic in Dublin, the prevalence of M. genitalium was 3% (12 of 400 specimens; 95% confidence interval, 1.3–4.7%), and the prevalences of macrolide resistance (75%), fluoroquinolone resistance (33.3%), and multidrug resistance (33.3%) were very high.
The prevalence of Mycoplasma genitalium was 3% (12 of 400 specimens; 95% confidence interval, 1.3–4.7%) in urine samples from men who have sex with men in Dublin, Ireland, with 75% of samples resistant to macrolides and 33% resistant to fluoroquinolones.
From the *Department of Microbiology, St James's Hospital;
†Dublin Institute of Technology;
‡Gay Men's Health Service, Baggot Street Hospital, Dublin, Ireland;
§WHO Collaborating Centre for Gonorrhoeae and other STIs, Department of Laboratory Medicine, Örebro University, Örebro, Sweden;
¶Department of Virology, St James's Hospital, Dublin, Ireland
Conflicts of Interest: None declared.
Sources of Funding: This work was supported by funds from the laboratory at St James's Hospital.
Correspondence: Brendan Crowley, MD, Department of Virology, St James's Hospital, Dublin, Ireland. E-mail: email@example.com.
Received for publication August 10, 2018, and accepted October 29, 2018.